TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33203625

Group type: EXPERIMENTAL
Intervention: PQT (esomeprazole 20 mg, amoxicillin 1 g, clarithromycin 500 mg, polaprezinc 75 mg)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Bismuth-containing quadruple therapy (esomeprazole 20 mg, amoxicillin 1 g, clarithromycin 500 mg, bismuth potassium citrate 220 mg)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: PQT
Number of subjects: 158

Group type: COMPARATOR
Intervention: Bismuth-containing quadruple therapy
Number of subjects: 158
Study: 34882169

Group type: EXPERIMENTAL
Intervention: 150 mg of armodafinil
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: 250 mg of armodafinil
Number of subjects: 328

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Corticosteroid users
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Nonusers of corticosteroids
Number of subjects: 328
Study: 33624514

Group type: EXPERIMENTAL
Intervention: Usual care + peer-befriending
Number of subjects: 56

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 56
Study: 32799849

Group type: EXPERIMENTAL
Intervention: Habit-based resistance training program (one set of push-ups, angled-rows, and bodyweight-squats performed every weekday for 12 weeks)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Habit-based resistance training program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 60
Study: 36314769

Group type: EXPERIMENTAL
Intervention: High-priority action plan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-priority action plan
Number of subjects: 0
Study: 34485219

Group type: EXPERIMENTAL
Intervention: Acupuncture plus MMT
Number of subjects: 123

Group type: COMPARATOR
Intervention: MMT (Control)
Number of subjects: 123
Study: 35844628

Group type: EXPERIMENTAL
Intervention: Customized messages about health risks and benefits of COVID-19 vaccination, including celebrity endorsements.
Number of subjects: 2621

Group type: EXPERIMENTAL
Intervention: Endorsement from Dr. Fauci.
Number of subjects: 2621
Study: 34813963

Group type: EXPERIMENTAL
Intervention: Personalized, goal-oriented text messages regarding dietary choices
Number of subjects: 162

Group type: COMPARATOR
Intervention: Attention control group receiving text messages about healthy pregnancy, labor, delivery, and early infancy
Number of subjects: 162
Study: 35168638

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine, Oseltamivir and Azithromycin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 32862403

Group type: EXPERIMENTAL
Intervention: Red LED (R)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Infrared LED (IR)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Red LED + Infrared LED (R + IR)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Sham (S)
Number of subjects: 63
Study: 35023846

Group type: EXPERIMENTAL
Intervention: Peer-supported Moving Forward
Number of subjects: 81

Group type: COMPARATOR
Intervention: Self-directed Moving Forward
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Both interventions (with and without peer support)
Number of subjects: 81
Study: 32444553

Group type: EXPERIMENTAL
Intervention: Multimodal lifestyle intervention (INT) including bright light therapy (BLT), physical activity (PA), and sleep hygiene education
Number of subjects: 96

Group type: COMPARATOR
Intervention: Education + attentional control (CON)
Number of subjects: 96
Study: 36811372

Group type: EXPERIMENTAL
Intervention: Nutrition + exercise intervention
Number of subjects: 17

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 17
Study: 32045087

Group type: EXPERIMENTAL
Intervention: Experience-based co-design (EBCD) method adapted for a multi-site setting
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Theory-informed analysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cluster randomized controlled trial
Number of subjects: 0
Study: 35422136

Group type: EXPERIMENTAL
Intervention: Bilateral peritoneal flap (PIF)
Number of subjects: 530

Group type: COMPARATOR
Intervention: No PIF (Control group)
Number of subjects: 530
Study: 33534743

Group type: EXPERIMENTAL
Intervention: Household playspace (HPS) intervention
Number of subjects: 0
Study: 32847918

Group type: EXPERIMENTAL
Intervention: Smartphone Cardiac Rehabilitation, Assisted self-Management (SCRAM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care cardiac rehabilitation (UC)
Number of subjects: 0
Study: 36146944

Group type: COMPARATOR
Intervention: Everolimus 10 mg once daily
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Sapanisertib 30 mg once weekly
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Sapanisertib 4 mg plus TAK-117 200 mg, both once daily for 3 days/week
Number of subjects: 95
Study: 32945153

Group type: EXPERIMENTAL
Intervention: Baricitinib 2 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baricitinib 10 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36097401

Group type: EXPERIMENTAL
Intervention: Jacobson's Relaxation Technique (JRT)
Number of subjects: 312
Study: 33112022

Group type: EXPERIMENTAL
Intervention: Valsalva maneuver
Number of subjects: 84

Group type: COMPARATOR
Intervention: Tenaculum
Number of subjects: 84
Study: 34985381

Group type: EXPERIMENTAL
Intervention: Blood pressure <120mmHg
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Melancholic subtype
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Na+/K+ ratio
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: K+ concentration
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Genetic variation of MR-related genes
Number of subjects: 826
Study: 34722452

Group type: EXPERIMENTAL
Intervention: Machine learning model using random forest algorithm for predicting sepsis
Number of subjects: 4449

Group type: COMPARATOR
Intervention: Validation data set
Number of subjects: 4449
Study: 32419688

Group type: EXPERIMENTAL
Intervention: Nutrition education and dietary counselling
Number of subjects: 257
Study: 35813435

Group type: EXPERIMENTAL
Intervention: Sandplay therapy (8 individual box court game tutoring sessions, once a week)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Sandplay therapy
Number of subjects: 72
Study: 34410046

Group type: EXPERIMENTAL
Intervention: Cytological analysis of EUS-FNA samples
Number of subjects: 63
Study: 36454123

Group type: EXPERIMENTAL
Intervention: EME+J
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: DB+J
Number of subjects: 61

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 61
Study: 34400461

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) added to usual care
Number of subjects: 2510

Group type: COMPARATOR
Intervention: Placebo added to usual care
Number of subjects: 2510
Study: 32305456

Group type: EXPERIMENTAL
Intervention: Strength for U in Relationship Empowerment (SURE)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 186
Study: 35296490

Group type: EXPERIMENTAL
Intervention: Integrative Body-Mind-Spirit (I-BMS) intervention delivered to both parents and children
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Integrative Body-Mind-Spirit (I-BMS) intervention delivered to parents only
Number of subjects: 192

Group type: COMPARATOR
Intervention: Health education active control delivered to parents only
Number of subjects: 192
Study: 32066548

Group type: EXPERIMENTAL
Intervention: Video group (self-recorded eye movement videos during attacks)
Number of subjects: 60
Study: 616743266

Group type: EXPERIMENTAL
Intervention: Regular Attendance at MSG sessions during the 6-month postpartum period
Number of subjects: 88

Group type: COMPARATOR
Intervention: Non-Regular Attendance at MSG sessions
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Older than 32 years
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Booking for antenatal care before 22 weeks gestational age
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Being on antiretroviral therapy at first antenatal care booking
Number of subjects: 88
Study: 36458504

Group type: EXPERIMENTAL
Intervention: Self-selected motivational music (WUMM)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Non-preferred music (WUNPM)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No music (WUWM)
Number of subjects: 10
Study: 33592827

Group type: EXPERIMENTAL
Intervention: CONSULT-BP intervention (3-part program combining knowledge acquisition, bias awareness, and practice of bias mitigating skills in simulation-based communication encounters)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: CONSULT-BP intervention
Number of subjects: 3
Study: 32801342

Group type: EXPERIMENTAL
Intervention: l-DOPA 100/25 mg
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: l-DOPA 200/50 mg
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 35676006

Group type: EXPERIMENTAL
Intervention: Intraoperative cell salvage and autotransfusion
Number of subjects: 1128

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1128
Study: 34112535

Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program (27 weeks, divided into 3 phases of 9 weeks each)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program
Number of subjects: 0
Study: 32481262

Group type: EXPERIMENTAL
Intervention: Lenke radiological grading scale
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bridwell radiological grading scale
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BSF (Brantigan, Steffe, Fraser) radiological grading scale
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CT-HU radiological grading scale
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Successful clinical outcome (SCO) defined as significant improvement in 2 of 3 of L-vas, R-vas, or ODI score at follow-up
Number of subjects: 0
Study: 35922251

Group type: EXPERIMENTAL
Intervention: Cemiplimab (350 mg intravenously every 3 weeks)
Number of subjects: 608

Group type: COMPARATOR
Intervention: Chemotherapy (investigator's choice)
Number of subjects: 608
Study: 32542515

Group type: EXPERIMENTAL
Intervention: Neuronavigated rTMS (10 Hz, 90% of resting motor threshold, 1,600 pulses over 20 min twice per day) for five days
Number of subjects: 74

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 74
Study: 33528092

Group type: EXPERIMENTAL
Intervention: Topical acidified aliphatic ester
Number of subjects: 32
Study: 36564142

Group type: EXPERIMENTAL
Intervention: Degenerative fibroelastic chords
Number of subjects: 43

Group type: COMPARATOR
Intervention: Normal chords
Number of subjects: 43
Study: 33395336

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 0
Study: 35882474

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Dual treatment
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: HFL treatment
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Dual, HFL, and RF treatments
Number of subjects: 31
Study: 32276098

Group type: EXPERIMENTAL
Intervention: PALO 0.25 mg IV infusion (30-minute infusion)
Number of subjects: 440

Group type: COMPARATOR
Intervention: PALO 0.25 mg IV bolus (30-second bolus)
Number of subjects: 440
Study: 35909478

Group type: EXPERIMENTAL
Intervention: PDCA nursing management
Number of subjects: 90

Group type: COMPARATOR
Intervention: Routine nursing management
Number of subjects: 90
Study: 32681234

Group type: EXPERIMENTAL
Intervention: Kabat rehabilitation + facial taping
Number of subjects: 20

Group type: COMPARATOR
Intervention: Kabat rehabilitation
Number of subjects: 20
Study: 32420357

Group type: COMPARATOR
Intervention: HLA-Bw4
Number of subjects: 77

Group type: COMPARATOR
Intervention: KIR3DL1-HLA-Bw4 combination
Number of subjects: 77
Study: 32150657

Group type: EXPERIMENTAL
Intervention: Feed Deprivation
Number of subjects: 8

Group type: COMPARATOR
Intervention: Fed Conditions
Number of subjects: 8
Study: 34552329

Group type: EXPERIMENTAL
Intervention: OMACOR (OM3EE) 2 g/day for 4 weeks, then 4 g/day for 8 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: OMACOR (OM3EE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35704055

Group type: EXPERIMENTAL
Intervention: Home-based resistance exercise (HBRE) program for 12 weeks
Number of subjects: 72

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 72
Study: 34121351

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 71

Group type: COMPARATOR
Intervention: Locally developed stress reduction program (LSR)
Number of subjects: 71
Study: 32564260

Group type: EXPERIMENTAL
Intervention: Pertuzumab, trastuzumab, and docetaxel
Number of subjects: 243

Group type: COMPARATOR
Intervention: Placebo, trastuzumab, and docetaxel
Number of subjects: 243
Study: 34164754

Group type: EXPERIMENTAL
Intervention: Surgical drill guide (SDG)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Surgical drill guide with implant insertion guide (SDIG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison of SDG and SDIG
Number of subjects: 30
Study: 34070917

Group type: EXPERIMENTAL
Intervention: Probiotic (Duolac ProAP4)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 34455631

Group type: EXPERIMENTAL
Intervention: Topical application of β‐NAG2 lotion for 8 weeks
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo lotion for 8 weeks
Number of subjects: 33
Study: 32689617

Group type: EXPERIMENTAL
Intervention: Joint mobilization
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Active stretching
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combination (joint mobilization and active stretching)
Number of subjects: 45
Study: 36501060

Group type: EXPERIMENTAL
Intervention: p-synephrine (3 mg/kg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (3 mg/kg cellulose)
Number of subjects: 16
Study: 34051823

Group type: EXPERIMENTAL
Intervention: Infographic 1
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Infographic 2
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Infographic 3
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Infographic 4
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Infographic 5
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: All infographics
Number of subjects: 100
Study: 32141627

Group type: EXPERIMENTAL
Intervention: Statin use pre-diagnosis
Number of subjects: 4315

Group type: EXPERIMENTAL
Intervention: Statin use 6 months post-diagnosis
Number of subjects: 4315

Group type: EXPERIMENTAL
Intervention: Statin use during entire follow-up
Number of subjects: 4315

Group type: EXPERIMENTAL
Intervention: Statin use (dose intensity analysis) 6 months post-diagnosis
Number of subjects: 4315
Study: 36368598

Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Reduction in deep subcutaneous adipose tissue (dSAT)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Reduction in visceral adipose tissue volume
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Reduction in dSAT and MRI hepatic proton density fat fraction (PDFF)
Number of subjects: 76
Study: 32577886

Group type: EXPERIMENTAL
Intervention: Vitamin B complex supplements
Number of subjects: 331

Group type: COMPARATOR
Intervention: Control group (blank control)
Number of subjects: 331
Study: 35340059

Group type: EXPERIMENTAL
Intervention: Double-syringe technique (DST)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Single-syringe technique (SST)
Number of subjects: 30
Study: 33058054

Group type: EXPERIMENTAL
Intervention: Robotic gastrectomy
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Robotic gastrecty
Number of subjects: 38
Study: 32051020

Group type: EXPERIMENTAL
Intervention: Ronopterin (VAS203)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34075118

Group type: EXPERIMENTAL
Intervention: Grating group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 35405933

Group type: EXPERIMENTAL
Intervention: 5 g/kg body mass (BM)/d
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 7 g/kg body mass (BM)/d
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 10 g/kg body mass (BM)/d
Number of subjects: 8
Study: 33852360

Group type: EXPERIMENTAL
Intervention: COVID-19 pneumonia
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Influenza pneumonia
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Organizing pneumonia (OP)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Favored diagnoses for COVID-19
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Favored diagnoses for influenza
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Favored diagnoses for OP
Number of subjects: 150
Study: 35577011

Group type: EXPERIMENTAL
Intervention: Comprehensive geriatric assessment adapted to primary care
Number of subjects: 369

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 369
Study: 32227756

Group type: EXPERIMENTAL
Intervention: Invasive strategy (coronary angiography and revascularization if appropriate added to medical therapy)
Number of subjects: 777

Group type: COMPARATOR
Intervention: Conservative strategy (medical therapy alone, angiography reserved for those in whom medical therapy had failed)
Number of subjects: 777

Group type: EXPERIMENTAL
Intervention: Invasive strategy
Number of subjects: 777

Group type: COMPARATOR
Intervention: Conservative strategy
Number of subjects: 777
Study: 35256192

Group type: EXPERIMENTAL
Intervention: Growth hormone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 0
Study: 33357682

Group type: EXPERIMENTAL
Intervention: 1,000 mg/kg benzoic acid (BA1)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: 2,000 mg/kg benzoic acid (BA2)
Number of subjects: 720

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 720
Study: 33417838

Group type: EXPERIMENTAL
Intervention: Chlamydia and gonorrhoea testing via urine samples using the Xpert CT/NG test in four intervention clusters.
Number of subjects: 4440
Study: 32020621

Group type: EXPERIMENTAL
Intervention: Therapist feedback on therapeutic alliance (TA)
Number of subjects: 155

Group type: COMPARATOR
Intervention: No therapist feedback on therapeutic alliance (TA)
Number of subjects: 155
Study: 35667730

Group type: EXPERIMENTAL
Intervention: Postoperative lidocaine infusion at 1.33 mg/kg/hour
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32369853

Group type: EXPERIMENTAL
Intervention: CloFAL assay
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: D-dimer
Number of subjects: 87
Study: 34020705

Group type: EXPERIMENTAL
Intervention: High-dose intravenous vitamin C
Number of subjects: 1

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 1
Study: 32989605

Group type: EXPERIMENTAL
Intervention: Genetically predicted higher physical activity (PA) level
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MR-Egger and weighted median methods
Number of subjects: 0
Study: 32198617

Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 90
Study: 35660372

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (twice a week for 30 min for 8 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional drug treatment
Number of subjects: 30
Study: 33826158

Group type: EXPERIMENTAL
Intervention: Center-based exercise training (ET) within a cardiac rehabilitation (CR) program; specific dosage and duration not mentioned.
Number of subjects: 256

Group type: COMPARATOR
Intervention: Control group (not specified in detail); specific intervention details not mentioned.
Number of subjects: 256
Study: 32078090

Group type: EXPERIMENTAL
Intervention: Ingestion of 200 mL of still mineral water
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ingestion of 400 mL of still mineral water
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ingestion of 600 mL of still mineral water
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ingestion of 800 mL of still mineral water
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: All volumes of water greater than 200 mL
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Time effects on heart rate variability parameters
Number of subjects: 8
Study: 34039154

Group type: EXPERIMENTAL
Intervention: Virtual reality game playing (1 hour per day, 5 days a week for 4 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Patching (occlusion of non-amblyopic eye for 2, 4, and 6 hours based on severity)
Number of subjects: 50
Study: 36079790

Group type: EXPERIMENTAL
Intervention: EAA+ (9 g EAAs, 3 g leucine)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: BCAAs (6 g BCAAs, 3 g leucine)
Number of subjects: 12

Group type: COMPARATOR
Intervention: CHO placebo
Number of subjects: 12

Group type: COMPARATOR
Intervention: REST and CHO placebo
Number of subjects: 12
Study: 33638810

Group type: EXPERIMENTAL
Intervention: Leuprorelin for ≥ 3 years with tamoxifen
Number of subjects: 222

Group type: COMPARATOR
Intervention: Leuprorelin for 2 years with tamoxifen
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Leuprorelin for ≥ 3 years with tamoxifen in higher-risk subgroup (n = 17)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Leuprorelin for 2 years with tamoxifen in higher-risk subgroup (n = 17)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Both treatment groups (≥ 3 years and 2 years)
Number of subjects: 222
Study: 36170006

Group type: EXPERIMENTAL
Intervention: 3-month caloric restriction
Number of subjects: 50

Group type: COMPARATOR
Intervention: Active waiting group
Number of subjects: 50
Study: 34585700

Group type: EXPERIMENTAL
Intervention: 100 g of PEITC-rich vegetable sauce
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 50 g of PEITC-rich vegetable sauce
Number of subjects: 21

Group type: COMPARATOR
Intervention: 100 g of placebo sauce
Number of subjects: 21